Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5087182
Max Phase: Preclinical
Molecular Formula: C47H59FN12O7
Molecular Weight: 923.06
Molecule Type: Unknown
Associated Items:
ID: ALA5087182
Max Phase: Preclinical
Molecular Formula: C47H59FN12O7
Molecular Weight: 923.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)n1cnc2c(NCc3nc4cc(F)c(NCCCCCCCCCCCCNC(=O)COc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)cc4[nH]3)nc(N3CCOCC3)nc21
Standard InChI: InChI=1S/C47H59FN12O7/c1-29(2)59-28-52-41-42(56-47(57-43(41)59)58-20-22-66-23-21-58)51-26-37-53-33-24-31(48)32(25-34(33)54-37)49-18-11-9-7-5-3-4-6-8-10-12-19-50-39(62)27-67-36-15-13-14-30-40(36)46(65)60(45(30)64)35-16-17-38(61)55-44(35)63/h13-15,24-25,28-29,35,49H,3-12,16-23,26-27H2,1-2H3,(H,50,62)(H,53,54)(H,51,56,57)(H,55,61,63)
Standard InChI Key: XFQJVHJSHJOCAP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 923.06 | Molecular Weight (Monoisotopic): 922.4614 | AlogP: 5.78 | #Rotatable Bonds: 23 |
Polar Surface Area: 230.69 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 19 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.50 | CX Basic pKa: 6.20 | CX LogP: 4.75 | CX LogD: 4.74 |
Aromatic Rings: 5 | Heavy Atoms: 67 | QED Weighted: 0.04 | Np Likeness Score: -1.16 |
1. Niu T, Li K, Jiang L, Zhou Z, Hong J, Chen X, Dong X, He Q, Cao J, Yang B, Zhu CL.. (2022) Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor., 228 [PMID:34864331] [10.1016/j.ejmech.2021.114012] |
Source(1):